Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Australia
Clinical trial register · Australia

Clinical Trials in Australia

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3378 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:19 UTC
3378
Studies in scope
all four open statuses
1824
Recruiting now
open to new participants
781
Lead sponsors
across recruiting studies
Top sites
Camperdown 9 Heidelberg 8 Westmead 8 Chermside 8 Adelaide 7

Trials in this register

35 of 3378 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Boehringer Ingelheim
Phase 3
270
Campbelltown, Wollongong, Ivanhoe, Nedlands
2026-12-14
Not yet open
Boehringer Ingelheim
Phase 1
200
Camperdown, Adelaide
2026-12-07
Recruiting
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT07707895Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology, Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
Boehringer Ingelheim
Phase 1/2
60
Camperdown, St Leonards
2026-11-03
Recruiting
Boehringer Ingelheim
Phase 1/2
55
Camperdown, Douglas
2026-10-01
Recruiting
Boehringer Ingelheim
Phase 3
466
Camperdown, Sydney, Chermside, Murdoch
2026-09-17
Recruiting
Boehringer Ingelheim
Phase 3
600
Camperdown, Meadowbrook, Oaklands Park, Melbourne
2026-08-24
Recruiting
Boehringer Ingelheim
Phase 3
448
Westmead, Adelaide, Fitzroy
2026-07-27
Recruiting
Boehringer Ingelheim
Phase 3
35
North Adelaide
2026-07-21
Recruiting
Boehringer Ingelheim
Phase 3
390
St Leonards, Bedford Park, Melbourne, Murdoch
2026-07-10
Active, closed
Boehringer Ingelheim
Phase 2
345
Camperdown, Maroochydore, Oaklands Park, Box Hill
2026-06-30
Recruiting
Boehringer Ingelheim
Phase 2
405
Heidelberg, Murdoch
2026-04-20
Recruiting
Boehringer Ingelheim
Phase 3
670
Randwick, Adelaide, Ballarat
2026-04-13
Recruiting
Boehringer Ingelheim
Phase 2
132
Concord, Kingswood, New Lambton Heights, Brisbane, Woolloongabba
2026-03-23
Recruiting
Boehringer Ingelheim
Phase 3
1,325
Campbelltown, Liverpool, New Lambton Heights, Adelaide, Box Hill, Clayton, Parkville
2026-02-17
Recruiting
Boehringer Ingelheim
Phase 3
286
Concord, Kingswood, Kogarah, Westmead, Herston, Southport, Adelaide, Parkville
2026-02-16
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
NCT07201922Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
80
Camperdown, Chermside, Melbourne
2026-02-10
Recruiting
Boehringer Ingelheim
Phase 3
400
Bedford Park, Subiaco, Heidelberg, Sydney, Woolloongabba
2026-01-16
Active, closed
Boehringer Ingelheim
Phase 3
135
Westmead, South Brisbane, Clayton, Parkville
2025-12-09
Active, closed
Boehringer Ingelheim
Phase 2
81
Chermside, Clayton, Nedlands
2025-11-13
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
414
Camperdown, Sydney, Darlinghurst, Chermside, Heidelberg, Murdoch
2025-09-13
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Garran, Blactown, Burwood, Camperdown, Concord, Liverpool, New Lambton Heights, St Leonards
2025-07-22
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Garran, Camperdown, North Ryde, Westmead, Chelmer, Chermside, Greenslopes, South Brisbane
2025-06-09
Active, closed
Boehringer Ingelheim
Phase 2
90
Randwick, Woolloongabba
2024-12-30
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Concord, Kingswood, Liverpool, Westmead, Clayton, Heidelberg, Parkville, Perth
2024-11-12
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Concord, Kingswood, Liverpool, Westmead, Birtinya, Clayton, Heidelberg, Parkville
2024-10-14
Recruiting
Boehringer Ingelheim
Phase 2
588
Macquarie Park, St Leonards, Woolloongabba, Adelaide, Subiaco
2024-10-11
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Garran, Camperdown, Westmead, Chermside, Adelaide, Heidelberg, Melbourne, Murdoch
2024-09-26
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Concord, Gosford, Kingswood, Kogarah, Liverpool, Port Macquarie, Pialba, Southport
2024-08-30
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Garran, Concord, Gosford, Kingswood, Kotara, Brisbane, Chermside, Tugun
2024-06-17
Active, closed
Boehringer Ingelheim
Phase 3
428
Randwick, St Leonards, Woolloongabba, Heidelberg, Subiaco
2024-02-09
Active, closed
Boehringer Ingelheim
Phase 2
268
Macquarie Park, Westmead, Chermside, South Brisbane, Nedlands, Spearwood
2023-09-08
Recruiting
Boehringer Ingelheim
Phase 1
554
Macquarie Park
2021-07-02
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-australia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,378 studies in total at the last sync on 14 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Australia?

22 of the 35 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 35 studies
PhaseStudiesRecruitingShare
Phase 3211560%
Phase 28422.9%
Phase 14111.4%
Phase 1/2225.7%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Boehringer Ingelheim3522

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Interstitial Lung Diseases (3) Bronchiectasis (2) Idiopathic Pulmonary Fibrosis (2) Lung Cancer, Non-squamous, Non-small Cell (2) Solid Tumours (2) Systemic Lupus Erythematosus (1) Advanced or Metastatic Solid Tumors With KRAS G12D Mutation (1) Progressive Pulmonary Fibrosis (1) Familial Pulmonary Fibrosis (1) Interstitial Lung Abnormalities (1) Extensive-stage Small Cell Lung Carcinoma (1) Advanced Small Cell Lung Cancer (1) Extrapulmonary Neuroendocrine Cancer (epNEC) (1) Chronic Kidney Disease (1) Acute Ischemic Stroke (1)
→

Browse trials by site location

Camperdown (9) Heidelberg (8) Westmead (8) Chermside (8) Adelaide (7) Concord (7) Murdoch (6) St Leonards (6) Kingswood (6) Clayton (5) Parkville (5) Liverpool (5) Woolloongabba (5) Garran (4) Melbourne (4)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.